Noopept

What it is

Noopept (N-phenylacetyl-L-prolylglycine ethyl ester, also called GVS-111) is a synthetic dipeptide compound developed in Russia in the 1990s. It is technically a peptide derivative rather than a true peptide — the structure includes an ethyl ester modification that distinguishes it from natural amino acid sequences.

Noopept is approved as a pharmaceutical in Russia for cognitive disorders. It is not FDA-approved for any use in the United States.

Mechanism of action

Proposed mechanisms come from laboratory and animal research:

• BDNF and NGF expression: increases were reported in the hippocampus of rats
• Cholinergic effects: reported in animal models of memory and learning
• GABAergic effects: anxiety-related behavioral changes were reported in animal studies
• Neuroprotective effects: reported in animal models of cognitive impairment

Despite the dipeptide structure, Noopept has been reported to have small-molecule-like pharmacokinetics with oral absorption, distinguishing it from most peptides.

Clinical evidence

Small studies have been published, mainly in Russia, in people with cerebrovascular and post-traumatic cognitive disorders; benefit in people has not been established, and these findings have not been evaluated by the FDA. Western replication is limited, and well-controlled human trials establishing effectiveness and safety are lacking.

Why we don’t prescribe it at The Tide

The Tide does not prescribe Noopept. Its structure and pharmacology are closer to small-molecule compounds than to peptides, and it has no FDA approval or established clinical pathway in the United States. Cognitive symptoms warrant evaluation by a licensed healthcare provider.

Side effects and contraindications

Human safety has not been established in well-controlled trials, and long-term effects are unknown. Headache, sleep disturbance, and mood changes have been reported. No safety data are available for pregnancy or breastfeeding. Products sold outside regulated channels may vary in purity, dose, and identity.